Lung Cancer

Radiotherapy for Patients With Completely Resected Pathologic IIIA(N2) Non-Small-Cell Lung Cancer: A Retrospective Analysis

Publish Date January 24, 2020

[Cancer Management and Research] A retrospective review sought to determine the effect of postoperative radiotherapy on patients with stage IIIA(N2) non-small cell lung cancer with EGFR mutation.

Study Supports Standard-Dose RT in Chemoradiotherapy for Patients With Stage III Unresectable NSCLC

By

Susan Moench, PhD, PA-C

Publish Date January 24, 2020

Long-term follow-up of the Radiation Therapy Oncology Group 0617 trial continues to support a 60-Gy radiation therapy dose as the standard of care.

Cancer Mortality Continuing to Drop, With Lung Cancer a Driver

Publish Date January 10, 2020

However, decreases in cancer mortality slowed for female breast cancer and CRC, ceased for prostate cancer.

BMI, Survival Linked in NSCLC Treated With Atezolizumab

Publish Date January 9, 2020

Overall, progression-free survival improved for patients with high BMI; link strongest with high PD-L1 expression.

Many Lung Cancer Patients Receive Meds That Prolong QTc Interval

Publish Date December 30, 2019

Receipt of these medications prolonging corrected QT interval limits patients’ eligibility for clinical trials.

Lung Cancer Clinical Trials

Clinical Trial: Protein and RNA Expression Patterns in Predicting Response to Treatment in Patients With Lung Cancer

Clinical Trial: Improving Management of Breathlessness in Patients With Lung Cancer

Clinical Trial: Lung Cancer Screening Study With Low-dose CT Scan and Blood Biomarker

Clinical Trial: Lung Cancer Biomarkers and Screening (NYULCBC)

Clinical Trial: Proton Therapy for Stage I Non-Small Cell Lung Cancer (LU03)